QGEN
Qiagen N.V.Company with tickers: QGEN
CIK
1015820
CUSIP
N72482156
Shares Outstanding
206,250,000
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $2,089,999,000 | USD | 2025-12-31 | 20-F | 2026-03-20 |
| Cost of Revenue | — | ||||
| Gross Profit | $1,299,495,000 | USD | 2025-12-31 | 20-F | 2026-03-20 |
| Operating Expenses | $833,644,000 | USD | 2025-12-31 | 20-F | 2026-03-20 |
| Research & Development | — | ||||
| Operating Income | $465,851,000 | USD | 2025-12-31 | 20-F | 2026-03-20 |
| Net Income | $424,880,000 | USD | 2025-12-31 | 20-F | 2026-03-20 |
| EPS (Basic) | $1.96 | USD/shares | 2025-12-31 | 20-F | 2026-03-20 |
| EPS (Diluted) | $1.94 | USD/shares | 2025-12-31 | 20-F | 2026-03-20 |